Oral Cancer Risk Assessment for Different Type of Smokeless Tobacco Products Sold Worldwide: A Review of Reviews and Meta-analyses

TY - JOUR

T1 - Oral Cancer Risk Assessment for Different Type of Smokeless Tobacco Products Sold Worldwide

T2 - A Review of Reviews and Meta-analyses

AU - Gupta, Alpana K.

AU - Kanaan, Mona

AU - Siddiqi, Kamran

AU - Sinha, Dhirendra N.

AU - Mehrotra, Ravi

N1 - This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

PY - 2022/11

Y1 - 2022/11

N2 - Smokeless tobacco (SLT) use is a significant cause of lip and oral cavity cancers. Globally, oral cancer prevalence is strongly linked to the types of tobacco products used, their chemical composition, and their pattern of use. Except snus, all SLT products sold in different World Health Organization regions are strongly associated with oral cancer incidence. Shammah showed the highest association OR with 95% confidence intervals (CI; OR, 38.74; 95% CI, 19.50–76.96), followed by oral snuff (OR, 11.80; 95% CI, 8.45–16.49), gutkha (OR, 8.67; 95% CI, 3.59–20.93), tobacco with betel quid (OR, 7.74; 95% CI, 5.38–11.13), toombak (OR, 4.72; 95% CI, 2.88–7.73), and unspecified chewing tobacco (OR, 4.72; 95% CI, 3.13–7.11). Most SLT products containing high levels of carcinogenic tobacco-specific nitrosamines (TSNA) exhibit a high risk of oral cancer. There is an urgent need to frame and implement international policies for oral cancer prevention through legal control of the TSNA levels in all SLT product types.

AB - Smokeless tobacco (SLT) use is a significant cause of lip and oral cavity cancers. Globally, oral cancer prevalence is strongly linked to the types of tobacco products used, their chemical composition, and their pattern of use. Except snus, all SLT products sold in different World Health Organization regions are strongly associated with oral cancer incidence. Shammah showed the highest association OR with 95% confidence intervals (CI; OR, 38.74; 95% CI, 19.50–76.96), followed by oral snuff (OR, 11.80; 95% CI, 8.45–16.49), gutkha (OR, 8.67; 95% CI, 3.59–20.93), tobacco with betel quid (OR, 7.74; 95% CI, 5.38–11.13), toombak (OR, 4.72; 95% CI, 2.88–7.73), and unspecified chewing tobacco (OR, 4.72; 95% CI, 3.13–7.11). Most SLT products containing high levels of carcinogenic tobacco-specific nitrosamines (TSNA) exhibit a high risk of oral cancer. There is an urgent need to frame and implement international policies for oral cancer prevention through legal control of the TSNA levels in all SLT product types.

UR - http://www.scopus.com/inward/record.url?scp=85141004288&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-21-0567

DO - 10.1158/1940-6207.CAPR-21-0567

M3 - Article

C2 - 36095092

AN - SCOPUS:85141004288

SN - 1940-6207

VL - 15

SP - 733

EP - 745

JO - Cancer Prevention Research

JF - Cancer Prevention Research

IS - 11

ER -